- Home
- / Advanced Biomedical Technologies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Advanced Biomedical Technologies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$42.5 K
2024-10-29
Revenue
$123.6 K
FY, 2020
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 11.7K | 123.6K | |||||
| Cost of goods sold | 7.6K | 51.8K | |||||
| Gross profit | 4.1K | 71.8K | |||||
| Gross profit margin, % | 34.8% | 58.1% | |||||
| General and administrative expense | 543.4K | 514.5K | 374.4K | 342.0K | 561.2K | 324.0K | 224.5K |
| Operating expense total | 801.1K | 832.4K | 695.1K | 678.0K | 937.0K | 608.8K | 518.4K |
| Depreciation and amortization | 26.6K | 30.5K | 29.6K | 13.6K | 16.3K | 21.2K | 17.0K |
| EBIT | (827.8K) | (605.2K) | (461.3K) | (403.6K) | (634.0K) | (604.7K) | (446.6K) |
| EBIT margin, % | -5187.8% | -361.4% | |||||
| Interest income | 137.0 | 119.0 | 59.0 | 36.0 | 36.0 | 24.0 | 44.0 |
| Interest expense | 36.0 | 36.0 | 24.0 | 44.0 | |||
| Pre tax profit | (862.9K) | (724.7K) | (691.6K) | (953.3K) | (948.8K) | (672.0K) | |
| Net Income | (827.8K) | (862.9K) | (724.7K) | (691.6K) | (953.3K) | (948.8K) | (672.0K) |